ArticlePlastic and reconstructive surgery. Global open2025
Machine Learning-based Identification of Prognostic Factors for Surgical Management in Patients With NOS Sarcoma.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Upper- versus lower-extremity synovial sarcoma: distinct surgical pathways and postoperative morbidity in a 24-year cohort.Journal of cancer research and clinical oncology · 2026Article
- Interdisciplinary therapy of extremity soft tissue sarcomas: current evidence on systemic treatments and the role of reconstructive surgery.Innovative surgical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-otherwise specified (NOS) sarcomas, a diverse and diagnostically challenging group of mesenchymal malignancies, pose significant clinical dilemmas due to their variable clinical trajectories and therapeutic responses. This study utilizes advanced machine learning techniques, namely classification and regression trees and Shapley additive explanation (SHAP) values, to identify predictors of survival, metastatic progression, and recurrence within a well-defined patient cohort, aiming to improve risk stratification and individualized care strategies. Methods: Through the application of classification and regression trees and SHAP values to a cohort of 122 patients with NOS sarcoma, we identified critical factors impacting disease outcomes. Results: The study findings revealed that age and tumor diameter significantly influenced the development of metastasis, whereas body mass index and tumor grading were key predictors for relapse. Additionally, tumor size, location, and age were identified as influential factors for overall survival in patients with NOS sarcoma. These results have direct clinical relevance and can aid in risk stratification and surgical planning in this challenging patient population. Conclusions: Considering the comparatively small cohort with which the machine learning algorithm was trained, this study underscores the importance of considering age, tumor size, location, body mass index, and tumor grading in the management of NOS sarcomas, shedding light on factors that may impact clinical outcomes and guide personalized treatment strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.